Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: BIORELIANCE CORPORATION
Awarding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Funding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Period of performance: 2024-09-26 to 2026-09-24
Current total value of award: $248779
Description: FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY.